rs2305616
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005677.4(COLQ):c.600+40G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.439 in 1,611,564 control chromosomes in the GnomAD database, including 157,029 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.46 ( 16738 hom., cov: 31)
Exomes 𝑓: 0.44 ( 140291 hom. )
Consequence
COLQ
NM_005677.4 intron
NM_005677.4 intron
Scores
2
Splicing: ADA: 0.00007013
2
Clinical Significance
Conservation
PhyloP100: -1.31
Genes affected
COLQ (HGNC:2226): (collagen like tail subunit of asymmetric acetylcholinesterase) This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-15474188-C-T is Benign according to our data. Variant chr3-15474188-C-T is described in ClinVar as [Benign]. Clinvar id is 259862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-15474188-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.55 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.600+40G>A | intron_variant | ENST00000383788.10 | NP_005668.2 | |||
COLQ | NM_080538.2 | c.570+40G>A | intron_variant | NP_536799.1 | ||||
COLQ | NM_080539.4 | c.498+40G>A | intron_variant | NP_536800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.600+40G>A | intron_variant | 1 | NM_005677.4 | ENSP00000373298 | P4 |
Frequencies
GnomAD3 genomes AF: 0.464 AC: 70467AN: 151882Hom.: 16717 Cov.: 31
GnomAD3 genomes
AF:
AC:
70467
AN:
151882
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.428 AC: 107537AN: 251300Hom.: 23510 AF XY: 0.427 AC XY: 58059AN XY: 135828
GnomAD3 exomes
AF:
AC:
107537
AN:
251300
Hom.:
AF XY:
AC XY:
58059
AN XY:
135828
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.436 AC: 636338AN: 1459564Hom.: 140291 Cov.: 32 AF XY: 0.435 AC XY: 316272AN XY: 726288
GnomAD4 exome
AF:
AC:
636338
AN:
1459564
Hom.:
Cov.:
32
AF XY:
AC XY:
316272
AN XY:
726288
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.464 AC: 70540AN: 152000Hom.: 16738 Cov.: 31 AF XY: 0.461 AC XY: 34268AN XY: 74272
GnomAD4 genome
AF:
AC:
70540
AN:
152000
Hom.:
Cov.:
31
AF XY:
AC XY:
34268
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1499
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Congenital myasthenic syndrome 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at